UK Much of the new inward investment in the UK from international pharmaceutical companies is from those that wish their discovery science to be in close adjacency to the most successful basic science programmes in biomedicinein the world. The co-location of pharmaceutical discovery sciences adjacent to the best universities (AstraZeneca in Cambridge, Novo Nordisk…

Canada Canadian medtech at a glance: market value, number of companies, number of employees,export markets, spinoffs.   Key areas of expenditure in Canadian medtech: diagnostic imaging stands as the single largest therapeutic area served.   Canadian medical device export destinations; the US is far and away the largest market for Canadian…

Serbia Serbia macroeconomic factsheet including data on population, GDP, education and life expectancy. Serbia has risen 50 places in the World Bank’s ‘Doing Business’ rankings from 93rd in 2014 to 43rd in 2018. Serbia’s GDP per capita between 2008 and 2016. International comparison of healthcare spending growth and GDP growth between…

Pharma The top 10 pharmaceutical companies in Canada for 2016 in terms of total sales and market share. Johnson & Johnson leads the way with USD 2.93 billion in sales, followed by Novartis with USD 1.24 billion and TEVA with USD 1.19 billion.

Japan Number of consultations for drugs in Japan by category in 2016. Oncology drugs leads the way, followed by gastrointestinal drugs and respiratory tract drugs. The launch of new medicines for major non-communicable diseases in Japan from 2004-2016 in terms of both applications and approvals. Regenerative medicine product approvals in Japan…

Tunisia Tunisia’s GDP percentage change year on year. After suffering a major slump in 2011, the economy is now on the road to recovery.   In terms of ease of doing business, Tunisia lags behind the UAE and Morocco but fares better than Jordan, Egypt and Lebanon. Public spending accounts for…

Ukraine Healthcare expenditure as a share of GDP has shrunk dramatically in Ukraine since 2013. Hospitals bear the brunt of primary care in Ukraine. WHO standards require a far greater role for family doctors within the overall healthcare system. Life expectancy in Ukraine lags behind that of its neighbors and peers.…

Ukraine The Top 30 companies in Ukraine based on 2016 sales. Homegrown hero Farmak leads the way, with USD 88 million in sales for the year. French company Sanofi follows in second place.

Colombia Colombia macroeconomic snapshot. Colombia GDP 1996-2016. GDP growth in South Americabetween 2015 and 2018. Colombia stands out for economic reliability in a region of uncertainty. Per capita healthcare expenditure in Latin America; Colombia stood in 9th place in 2014. Colombia healthcare snapshot. Healthcare expenditure in Colombia up until 2021. Pharma…

Colombia The top 20 pharma companies in the Colombian retail market by market share. US-headquartered Abbott leads the way with 13.3%, followed by French outfit Sanofi with 8.7% and domestic champion Tecnoquimicas in third place with 8.5%. Click here to download the Healthcare & Life Sciences Review Colombia 2017

Hong Kong Hong Kong’s top 10 trading partners. Mainland China is by far the most significant partner in terms of both imports and exports. Hong Kong at a glance and its important relationship to the massive China market. Healthcare expenditure in Hong Kong as a percentage of GDP compared to other countries.…

Indonesia The Top 15 pharma companies in Indonesia for 2016. Local giant Kalbe Farma leads the way.